Clinical Trial: Clinical Trial of the Safety and Tolerability of the Drug MMH-450 in Healthy Volunteers

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07708623) titled 'Clinical Trial of the Safety and Tolerability of the Drug MMH-450 in Healthy Volunteers' on July 13.

Brief Summary: Open-label, non-comparative, non-randomized clinical trial of the safety and tolerability of the drug MMH-450 in healthy volunteers

Study Start Date: Aug. 15, 2025

Study Type: INTERVENTIONAL

Condition: Sleep Disorders

Intervention: DRUG: MMH-450

Duration of therapy - 7 days. Per os, without food. The tablet is kept in the mouth until completely dissolved.

Recruitment Status: COMPLETED

Sponsor: Materia Medica Holding

Disclaimer: Curated by HT Syndication....